


DARA Biosciences Revenue
Biotechnology Research • Raleigh, North Carolina, United States • 1-10 Employees
DARA Biosciences revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contacts at DARA Biosciences
Linda Jett
Clinical Director/Program Manager, Drug Development
Richard Franco
Ceo
Tracy Osborne Coward
Director, Hr
Company overview
| Headquarters | 8601 Six Forks Road Suite 160, Raleigh, North Carolina 27615, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About DARA Biosciences
DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. DARA sharpened its focus in oncology through its January 2012 acquisition of Oncogenerix, Inc., which holds the exclusive U.S. marketing rights to Soltamox®. Soltamox® is a novel oral liquid formulation of tamoxifen, a product used widely in the treatment and prevention of breast cancer. Soltamox® is the only FDA approved oral liquid version of tamoxifen and fulfills a vital clinical need for patients who cannot tolerate existing tablet formulations of this drug. DARA plans to begin marketing Soltamox® in the U.S. in the third quarter of 2012.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
DARA Biosciences has 6 employees across 5 departments.
Departments
Number of employees
Funding Data
DARA Biosciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



